Clinical observation on pericardiocentesis and glucocorticoid in the treatment of tuberculous pericarditis

OBJECTIVE: To investigate pericardiocentesis and glucocorticoids in the treatment of the clinical curative effect of tuberculous pericarditis. PATIENTS AND METHODS: Choose 128 cases of our hospital diagnosed as tuberculous pericarditis patients as the research object, according to the treatment, were divided into group A (pericardium puncture + anti-tuberculosis (anti-TB) treatment of 26 cases) and group B (pericardium puncture + anti-tuberculosis (anti-TB) + glucocorticoid treatment of 30 cases), group C (anti-tuberculosis (anti-TB) + glucocorticoid therapy of 24 cases, and group D anti-tuberculosis (anti-TB) treatment of 48 cases, in the treatment of 8 weeks, 3 months, 6 months, 9 months, 12 months, 18 months by B ultrasonic and CT examination to observe the efficacy of treatment. RESULTS: At 8 weeks after treatment in group A, group B and group C and group D efficient were 61.54%, 93.33%, 54.17%, and 68.75%, respectively, group B, respectively, compared with group A, group C, and group D, had obvious statistical significance difference (p < 0.05); Groups of early and late treatment comparison difference have no statistical significance (p > 0.05). CONCLUSIONS: Tuberculous pericarditis in anti-TB treatment on the basis of using pericardiocentesis and sugar cortical hormone treatment, can achieve an ideal effect.